Spero Therapeutics
SPRO
#9058
Rank
A$0.10 B
Marketcap
$2.02
Share price
-0.75%
Change (1 day)
16.00%
Change (1 year)

Earnings for Spero Therapeutics (SPRO)

Earnings in 2024 (TTM): A$24.22 Million

According to Spero Therapeutics's latest financial reports the company's current earnings are A$0.10 Billion. In 2023 the company made an earning of A$35.96 Million, an increase over its 2022 earnings that were of -A$67.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spero Therapeutics from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$24.22 M-32.65%
2023 A$35.96 M-153.57%
2022 -A$67.15 Million-50.14%
2021 -A$0.14 Billion11.06%
2020 -A$0.13 Billion25.15%
2019 -A$96.89 Million47.68%
2018 -A$65.61 Million5.61%
2017 -A$62.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$39.08 M 45.37%๐Ÿ‡บ๐Ÿ‡ธ USA
A$9.57 B 35,530.81%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.84 B 10,480.92%๐Ÿ‡จ๐Ÿ‡ฆ Canada